D
David A. Lieberman
Researcher at Oregon Health & Science University
Publications - 23
Citations - 3211
David A. Lieberman is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Colorectal cancer & Colonoscopy. The author has an hindex of 12, co-authored 23 publications receiving 2851 citations. Previous affiliations of David A. Lieberman include Indiana University – Purdue University Indianapolis & International Agency for Research on Cancer.
Papers
More filters
Journal ArticleDOI
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
David A. Lieberman,D G Weiss +1 more
TL;DR: One-time screening with both a fecal occult-blood test with rehydration and sigmoidoscopy fails to detect advanced colonic neoplasia in 24 percent of subjects with the condition.
Journal ArticleDOI
Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Francis M. Giardiello,John I. Allen,Jennifer E. Axilbund,C. Richard Boland,Carol A. Burke,Randall W. Burt,James M. Church,Jason A. Dominitz,David A. Johnson,Tonya Kaltenbach,Theodore R. Levin,David A. Lieberman,Douglas J. Robertson,Douglas J. Robertson,Sapna Syngal,Sapna Syngal,Douglas K. Rex +16 more
TL;DR: The Multi-Society Task Force developed guidelines to assist health care providers with the appropriate provision of genetic testing and management of patients at risk for and affected with Lynch syndrome.
Journal ArticleDOI
Nonpolypoid neoplastic lesions of the colorectal mucosa.
Shin ei Kudo,René Lambert,John I. Allen,Hiroaki Fujii,Takahiro Fujii,Hiroshi Kashida,Takahisa Matsuda,Masaki Mori,Hiroshi Saito,Tadakazu Shimoda,Shinji Tanaka,Hidenobu Watanabe,Joseph J.Y. Sung,Andrew D. Feld,John M. Inadomi,Michael J. O'Brien,David A. Lieberman,David F. Ransohoff,Roy Soetikno,George Triadafilopoulos,A G Zauber,Claudio Rolim Teixeira,Jean François Rey,Edgar Jaramillo,Carlos A. Rubio,Andre Van Gossum,Michael Jung,Michael Vieth,Jeremy R. Jass,Paul D. Hurlstone +29 more
Journal ArticleDOI
Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Francis M. Giardiello,John I. Allen,Jennifer E. Axilbund,C. Richard Boland,Carol A. Burke,Randall W. Burt,James M. Church,Jason A. Dominitz,David A. Johnson,Tonya Kaltenbach,Theodore R. Levin,David A. Lieberman,Douglas J. Robertson,Sapna Syngal,Douglas K. Rex +14 more
TL;DR: The Multi-Society Task Force developed guidelines to assist health care providers with the appropriate provision of genetic testing and management of patients at risk for and affected with Lynch syndrome.
Journal ArticleDOI
Five-year colon surveillance after screening colonoscopy.
David A. Lieberman,David G. Weiss,William V. Harford,Dennis J. Ahnen,Dawn Provenzale,Stephen J. Sontag,Thomas G. Schnell,Gregorio Chejfec,Donald R. Campbell,Jayashri Kidao,John H. Bond,Douglas B. Nelson,George Triadafilopoulos,Francisco C. Ramirez,Judith Collins,Tiina K. Johnston,Kenneth R. McQuaid,Harinder S. Garewal,Richard E. Sampliner,Romeo Esquivel,Douglas J. Robertson +20 more
TL;DR: There is a strong association between results of baseline screening colonoscopy and rate of serious incident lesions during 5.5 years of surveillance and patients with 1 or 2 tubular adenomas less than 10 mm represent a low-risk group compared with other patients with colon neoplasia.